ARTICLES BY THIS AUTHOR
- 6/7/2011
Safinamide disappoints in preventing dyskinesia in Parkinson's patients
The new drug safinamide might have some impact in preventing the involuntary movements characteristic of Parkinson's disease. However, it did not perform any better than placebo over a two-year period. - 6/7/2011
Regional riddle emerges from epilepsy drug study
New treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor - 6/7/2011
Alberta conference celebrates centennial
Official celebration to mark a century of practice in the province kicks off at Alberta Pharmacy Centennial Conference. - 6/6/2011
Byetta: second GLP-1 agonist for diabetes
Indicated for use in combination with metformin and/or a sulfonylurea to improve glycemic control in adults with type 2 diabetes. - 6/6/2011
Sea buckthorn, the mysterious shrub
I wanted to find out the benefits and uses of buckthorn oil. Is it available in a tablet/capsule format, or as an oil ? And if so, who manufactures it? - 6/6/2011
Collaboration on a cloud: Telus and Carefx
Telus Health Solutions is partnering with Carefx to create a set of services for clinicians and providers to access through a private cloud. - 6/6/2011
Video: The pharmacist your pharmacist could be...
UBC pharmacy students create spoof of wildly-popular Old Spice - 6/6/2011
Work begins on Ontario's final diagnostic imaging repository
Work on Ontario's fourth and largest diagnostic imaging repository is underway and will begin benefitting patients across the western parts of the Greater Toronto Area and North Simcoe Muskoka later this year. - 6/6/2011
Fraser Health opens Jim Pattison Outpatient Centre
The $237-million Jim Pattison Outpatient Care and Surgery Centre is officially open in Surrey, B.C. Within one building, it will offer day surgery, diagnostic procedures such as lab, X-ray, CT and MRI scans and biopsies, and specialized health programs. - 6/6/2011
Immunotherapy: Ready for prime time in 10 years?
Leading researchers are optimistic, but evidence is still too preliminary